Nemaura Medical Inc (NASDAQ:NMRD) reported first-quarter earnings Friday that showed raised cash reserves as the company kicked off the commercial launch of SugarBEAT, the world’s first painless glucose monitor. The Loughborough, UK-based medtech company revealed that, as of June 30, its combined cash balance was $3,068,541.
Alchemist Mining Inc (CSE:AMS) said Friday that it is tapping cannabis industry veteran Zeta Ceti to its board of directors. As the founder CEO of Green Rush Consulting, Ceti and his team have scored more than 100 cannabis licenses across the US. Alchemist is boosting its cannabis industry talent as it redefines itself as a technology solutions provider for the cannabis sector.
Mackie Research has repeated a Speculative Buy rating on drug developer Acasti Pharma Inc.(NASDAQ:ACST) (CVE:ACST) in the wake of news that its main competitor Amarin has received a setback on approval for its Vascepa heart drug. On Thursday, Amarin revealed that the US Food & Drug Administration (FDA) has scheduled an advisory committee (adcom) meeting on the drug for November 14 this year.
Roth Capital Partners has set a price target of US$7.50 on electric vehicle manufacturer ElectraMeccanica Vehicles Corp (NASDAQ:SOLO) after the company’s recent financials came in ahead of analyst estimates. The research firm noted that initiating production at Vancouver-based Meccanica’s Zongshen, China manufacturing facility would be a key catalyst for the company going forward.
Chanticleer Holdings, Inc. (NASDAQ:BURG), the owner, operator, and franchisor of multiple nationally recognized restaurant brands, said it will host a conference call on Wednesday August 14 at 4:30 pm Eastern Time to discuss its second quarter 2019 financial results which will be released prior to the call.
Empower Clinics Inc (CSE:CBDT) (OTCMKTS:EPWCF) is launching a “CEO verified” discussion forum on AGORACOM, a social media site that connects companies with the investment community. The CEO verified feature provides identity authentication for executives of small-cap companies and lets them post and communicate with investors without risk of impersonation.
Capstone Turbine Corporation (NASDAQ:CPST) revealed Friday that the clean technology company’s order book for low-emission microturbine energy systems filled up rapidly in the fiscal first quarter of 2020 and it shipped 9.5 megawatts of equipment. In a statement, the Van Nuys, California-based company said it booked new gross product orders of $17.4 million for a book-to-bill ratio of 1.7:1 in the fiscal first quarter, compared with $16.3 million in the same period in the previous year for a book-to-bill ratio of 1.2:1. This represents a 7% increase of $1.1 million year-over-year.
Progressive Planet Solutions Inc (CVE:PLAN) is offering a new service collecting denatured cannabis waste, and Valens Groworks Corp (CVE:VGW) (OTCMKTS:VGWCF) has taken them up on it. Since April, Progressive Planet has been providing Valens with zeolite, a gray, gravely mineral that can be used in water purification, hazardous waste containment, and crucially, denaturing hemp and cannabis waste.
Arcadia Biosciences Inc (NASDAQ:RKDA) announced Friday that its joint venture company Verdeca has received a green light from the United States Department of Agriculture (USDA) to commercialize a variety of drought-resistant soybean. The USDA approved the HB4 drought and water-stress resistant seed which Arcadia Biosciences developed jointly with Argentenia’s Bioceres Crop Solutions Corp (NYSEAMERICAN:BIOX), according to a company statement.
DXI Energy Inc (TSE:DXI) (OTCMKTS:DXIEF) revealed a number of financial highlights as the Canadian oil and gas company released its second quarter financial results on Thursday. Despite challenging market conditions in the oil sector, DXI raised gross proceeds of C$350,000 in the second quarter to support the ongoing development of its Woodrush project.
CUI Global Inc (NASDAQ:CUI), an energy infrastructure company, reported partial second-quarter results before Friday’s opening bell that showed narrowing losses and revenue just short of analysts’ expectations, and it trailed a potential acquisition and change of CEO. The company cut its second quarter losses by more than 40% year-on-year to $2.5 million from $.2 million.
Next Green Wave Holdings Inc. (CSE:NGW) (OTCQX:NXGWF) has accepted the resignation of its CEO and executive chairman Leigh Hughes as a senior officer and board member of the company due to health and personal priorities. The fully integrated premium cannabis producer said Hughes will continue his involvement with the company as an advisor to the board, in order to facilitate an orderly transition to new leadership.
Pacton Gold Inc. (CVE:PAC) has clarified that, further to its news release of July 29, the company will purchase a 100% interest in the Golden Loon property by paying $100,000 and issuing 400,000 common shares upon acceptance of the transaction by the TSX Venture Exchange. It also said the company will purchase a 100% interest in the Pakwash property by paying $100,000 and issuing 400,000 common shares upon acceptance of the transaction by the TSX Venture Exchange. The company had incorrectly reported that it would issue 200,000 common shares for each of the properties.
Xphyto Therapeutics Corp. (CSE:XPHY) has issued an aggregate of 2.5 million stock options in accordance with its stock option plan at an exercise price of $1.25 per share to certain consultants, directors and officers of the company. It said 700,000 options will expire on August 7, 2020, 400,000 options will expire on August 7, 2021 and 1,400,000 options will expire on August 7, 2024. The company said the options were granted 1,900,000 options vest as of the date of the grant, and 600,000 options will vest in stages - with 20% vesting immediately, and the remainder to vest 20% every six months from date of grant. The options and any common shares issued upon exercise will be subject to a four month and a day resale restriction from the date of grant. The option plan allows Xphyto’s board of directors to issue the equivalent of up to 10% of the company’s issued and outstanding share capital on a rolling basis.
Acasti Pharma Inc. (NASDAQ: ACST) (CVE:ACST) has announced that the company will be participating on a panel during the 2019 BTIG Biotechnology Conference being held on Monday, August 12, at the St. Regis in New York City. The biopharmaceutical innovator said Pierre Lemieux, its co-founder, chief operating and scientific officer, will be participating on a panel, entitled “Lipids: Moving Beyond Statins: Omega 3s, Bempedoic, and More,” at 11:00 am Eastern Time that will feature Harold Bays, MD, as a key opinion leader within the space. The conference - hosted by BTIG biotechnology analysts Robert “Bert” Hazlett, Amanda Murphy, and Thomas Shrader - will feature several of the industry’s key opinion leaders and other panelists from emerging and established biotechnology companies.